196 related articles for article (PubMed ID: 16964817)
1. Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy.
O'Gorman C; McMullan R; Webb CH; Bedi A
Ulster Med J; 2006 Sep; 75(3):226-7. PubMed ID: 16964817
[No Abstract] [Full Text] [Related]
2. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.
Bassetti M; Bisio F; Di Biagio A; Pierri I; Balocco M; Soro O; Cruciani M; Bassetti D
J Antimicrob Chemother; 2004 Aug; 54(2):575-7. PubMed ID: 15231763
[No Abstract] [Full Text] [Related]
3. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
6. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia.
Makowsky MJ; Warkentin DI; Savoie ML
Ann Pharmacother; 2005; 39(7-8):1365-6. PubMed ID: 15956243
[No Abstract] [Full Text] [Related]
7. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
[TBL] [Abstract][Full Text] [Related]
8. Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Rieger C; Geiger S; Herold T; Nickenig C; Ostermann H
Eur J Clin Microbiol Infect Dis; 2007 Nov; 26(11):843-5. PubMed ID: 17690928
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.
Serena C; Pastor FJ; Gilgado F; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2005 Feb; 49(2):497-502. PubMed ID: 15673724
[TBL] [Abstract][Full Text] [Related]
10. Combined therapies in a murine model of blastoschizomycosis.
Serena C; RodrÃguez MM; Mariné M; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2007 Jul; 51(7):2608-10. PubMed ID: 17452487
[TBL] [Abstract][Full Text] [Related]
11. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation.
Abdala E; Lopes RI; Chaves CN; Heins-Vaccari EM; Shikanai-Yasuda MA
Transpl Infect Dis; 2005; 7(3-4):162-5. PubMed ID: 16390408
[TBL] [Abstract][Full Text] [Related]
12. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
13. [Caspofungin in the replacement of amphotericin B in the treatment of fungal diseases].
Yang W; He B
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):53. PubMed ID: 15808079
[No Abstract] [Full Text] [Related]
14. [Disseminated Trichosporon asahii infection].
Servonnet A; Bourgault M; Trueba F; Sarret D; Nicand E
Ann Biol Clin (Paris); 2010; 68(3):363-6. PubMed ID: 20478783
[TBL] [Abstract][Full Text] [Related]
15. In vitro interaction of itraconazole with amphotericin B, caspofungin, and terbinafine against clinical isolates of Trichosporon asahii.
Li H; Qiao J; Wan Z; Zhang J
Mycopathologia; 2011 May; 171(5):345-8. PubMed ID: 21153882
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin versus liposomal amphotericin B for empirical therapy.
Tattevin P; Bareau B; Camus C
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675091
[No Abstract] [Full Text] [Related]
17. Caspofungin versus liposomal amphotericin B for empirical therapy.
Schneemann M; Imhof A
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675094
[No Abstract] [Full Text] [Related]
18. Trichosporon asahii fungemia in a patient with non-hematological malignancy.
Karabay O; Madariaga MG; Kocoglu E; Ince N; Kandirali E
Jpn J Infect Dis; 2006 Apr; 59(2):129-31. PubMed ID: 16632916
[TBL] [Abstract][Full Text] [Related]
19. Caspofungin versus liposomal amphotericin B for empirical therapy.
Danaher PJ
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
[No Abstract] [Full Text] [Related]
20. [Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Silva V; Zepeda G; Alvareda D
Rev Iberoam Micol; 2003 Mar; 20(1):21-3. PubMed ID: 12825977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
